Serum Response Factor (SRF), as a transcription factor, promotes epithelial cell migration and invasion in prostate cancer, gastric cancer, cervical cancer, and hepatocellular carcinoma and is associated with poor prognosis [169, 170, 171]. The gene discussed is SRF; the disease is gastric cancer.